Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Revance Therapeutics, Inc. (RVNC)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
5 Sep 2023
Moxie Dwight
SVP, GC & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
44,066
-44%
34,853
$17.58
$612,623.70
SELL
3 Aug 2023
Foley Mark J
CEO, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
840,375
-3%
26,279
$22.57
$593,151.20
SELL
30 Jun 2023
Foley Mark J
CEO, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
866,654
-2%
26,279
$24.94
$655,332.56
SELL
30 Jun 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
79,896
-2%
1,701
$25.04
$42,593.04
SELL
15 Jun 2023
Kolaja Carey OConnor
Director
Revance Therapeutics, Inc.
(RVNC)
16,561
-13%
2,500
$28.24
$70,600.00
SELL
9 Jun 2023
Sjuts Dustin S
President, Officer
Revance Therapeutics, Inc.
(RVNC)
147,347
-3%
5,000
$30.82
$154,096.00
SELL
9 Jun 2023
Foley Mark J
CEO, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
891,933
-3%
31,279
$30.72
$960,928.44
SELL
1 Jun 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
80,828
-3%
3,201
$30.64
$98,069.57
SELL
1 May 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
63,081
-4%
3,201
$31.70
$101,471.70
SELL
3 Apr 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
66,282
-4%
3,201
$32.15
$102,912.16
SELL
1 Mar 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
49,390
-6%
3,201
$33.50
$107,233.50
SELL
31 Jan 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
54,676
-5%
3,201
$34.60
$110,754.59
SELL
20 Jan 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
57,877
-1%
1,000
$31.00
$31,000.00
SELL
9 Jan 2023
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
60,877
-5%
3,701
$27.16
$100,525.00
SELL
14 Sep 2022
Moxie Dwight
SVP, GC & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
31,694
-25%
11,000
$27.07
$297,797.50
SELL
2 Feb 2022
Sjuts Dustin S
President, Officer
Revance Therapeutics, Inc.
(RVNC)
152,347
-12%
21,015
$34.55
$726,003.10
SELL
2 Feb 2022
Moxie Dwight
SVP, GC & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
69,165
-23%
21,401
$34.55
$739,338.25
SELL
2 Feb 2022
Schilke Tobin
CFO, Officer
Revance Therapeutics, Inc.
(RVNC)
84,029
-20%
21,401
$34.55
$739,338.25
SELL
2 Feb 2022
Foley Mark J
CEO, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
923,212
-7%
70,447
$34.55
$2,433,725.50
BUY
13 Dec 2021
Russell Angus C.
Director
Revance Therapeutics, Inc.
(RVNC)
26,913
+31%
6,400
$15.74
$100,741.12
BUY
3 Dec 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
95,463
+45%
30,000
$14.43
$432,876.00
BUY
29 Nov 2021
Foley Mark J
CEO, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
110,913
+56%
40,000
$12.90
$515,924.00
SELL
27 Sep 2021
Moxie Dwight
SVP, GC & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
47,804
-3%
1,675
$30.00
$50,250.00
SELL
15 Aug 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
65,463
-12%
9,364
$26.34
$246,659.00
SELL
28 Jul 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
321,611
-14%
54,332
$30.06
$1,632,960.00
SELL
26 Jul 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
355,943
-13%
55,382
$29.72
$1,645,953.00
SELL
5 Apr 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
411,325
-0%
2
$28.28
$56.56
SELL
4 Mar 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
411,327
-7%
33,119
$25.43
$842,216.20
SELL
1 Feb 2021
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
444,446
-6%
33,119
$25.95
$859,438.06
SELL
30 Dec 2020
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
477,565
-6%
33,119
$27.82
$921,211.60
SELL
30 Nov 2020
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
510,684
-6%
33,119
$23.85
$789,888.20
SELL
29 Oct 2020
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
543,803
-5%
33,119
$26.15
$865,949.25
SELL
28 Sep 2020
Rankin Aubrey
President, Innovation & Tech, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
576,922
-5%
33,119
$26.18
$867,055.44
SELL
15 Mar 2019
Allouche Cyril
Principal Accounting Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
6,400
-7%
498
$15.48
$7,709.04
SELL
15 Mar 2019
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
151,193
-7%
11,613
$15.51
$180,067.70
SELL
15 Feb 2019
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
168,943
-3%
5,446
$17.68
$96,285.28
SELL
22 Jan 2019
Allouche Cyril
Principal Accounting Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
4,000
-13%
625
$17.77
$11,106.25
SELL
3 Jan 2019
Allouche Cyril
Principal Accounting Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
4,000
-8%
375
$19.48
$7,305.00
SELL
20 Nov 2018
Allouche Cyril
Principal Accounting Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
4,000
-10%
491
$20.66
$10,144.06
SELL
9 Nov 2018
Allouche Cyril
Principal Accounting Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
4,750
-31%
2,188
$23.72
$51,899.36
SELL
6 Jul 2018
Allouche Cyril
Principal Financial Officer, Officer
Revance Therapeutics, Inc.
(RVNC)
4,750
-7%
393
$28.35
$11,141.55
SELL
22 May 2018
SILVERNAIL LAUREN P
CFO & CBO, Officer
Revance Therapeutics, Inc.
(RVNC)
65,497
-4%
2,874
$30.25
$86,924.41
SELL
22 Mar 2018
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
68,371
-4%
3,431
$30.85
$105,838.80
BUY
16 Mar 2018
Vickers Philip J.
Director
Revance Therapeutics, Inc.
(RVNC)
5,250
+150%
3,150
$31.24
$98,392.50
SELL
16 Mar 2018
GARDNER PHYLLIS
Director
Revance Therapeutics, Inc.
(RVNC)
3,000
-63%
5,333
$31.51
$168,045.50
SELL
15 Mar 2018
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
141,875
-4%
6,452
$31.64
$204,147.64
SELL
13 Mar 2018
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
72,954
-26%
25,867
$34.50
$892,411.50
SELL
7 Mar 2018
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
131,208
-17%
27,283
$31.43
$857,504.70
SELL
7 Mar 2018
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
72,954
-21%
20,000
$32.00
$640,000.00
SELL
22 Nov 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
133,188
-5%
7,600
$24.94
$189,569.83
BUY
7 Nov 2017
Foley Mark J
Director
Revance Therapeutics, Inc.
(RVNC)
19,500
+4000%
20,000
$26.96
$539,168.10
SELL
7 Nov 2017
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
49,006
-16%
10,000
$26.83
$268,267.00
SELL
18 Oct 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
140,788
-5%
7,662
$26.16
$200,404.98
SELL
12 Oct 2017
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
49,006
-18%
11,164
$26.67
$297,759.50
SELL
20 Sep 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
148,450
-4%
7,600
$23.58
$179,185.20
SELL
23 Aug 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
156,050
-12%
22,800
$22.76
$519,030.60
SELL
22 May 2017
SILVERNAIL LAUREN P
CFO, CBO & Secretary, Officer
Revance Therapeutics, Inc.
(RVNC)
36,566
-4%
1,793
$20.20
$36,212.15
SELL
22 May 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
164,219
-16%
32,000
$20.29
$649,249.90
SELL
22 Feb 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
200,659
-5%
11,037
$20.57
$227,050.44
SELL
25 Jan 2017
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
184,627
-6%
12,000
$19.78
$237,398.39
SELL
28 Dec 2016
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
195,627
-5%
12,000
$20.94
$251,250.00
SELL
25 Nov 2016
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
208,449
-5%
12,000
$17.92
$215,004.90
SELL
26 Oct 2016
Browne L Daniel
CEO and President, Director, Officer
Revance Therapeutics, Inc.
(RVNC)
219,627
-5%
12,000
$14.85
$178,198.80
SELL
13 Jun 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
23,944
-4%
1,000
$18.25
$18,250.00
SELL
9 May 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
25,264
-3%
1,000
$16.18
$16,180.00
SELL
11 Apr 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
25,264
-3%
1,000
$19.11
$19,110.00
SELL
7 Mar 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
25,264
-3%
1,000
$20.43
$20,430.00
SELL
8 Feb 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
17,264
-5%
1,000
$18.14
$18,140.00
SELL
6 Jan 2016
Ruegg Curtis
EVP, Technical Operations, Officer
Revance Therapeutics, Inc.
(RVNC)
18,027
-9%
2,000
$33.06
$66,120.00
Home